about
Treatment for osteoporosis in people with ß-thalassaemiaTreatment for osteoporosis in people with ß-thalassaemiaMetabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in TehranBone resorption is increased in young adults with thalassaemia major.Bone density in transfusion dependent thalassemia patients in Urmia, Iran.Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosisOsteoporosis syndrome in thalassaemia major: an overview.Endocrine complications of thalassemia.Characterization of low bone mass in young patients with thalassemia by DXA, pQCT and markers of bone turnoverComparative study of radiographic and laboratory findings between Beta thalassemia major and Beta thalassemia intermedia patients with and without treatment by hydroxyureaGenetic insights into the clinical diversity of beta thalassaemia.Prevalence of endocrinopathies in patients with Beta-thalassaemia major - a cross-sectional study in oman.Decreased Bone Formation Explains Osteoporosis in a Genetic Mouse Model of Hemochromatosiss.Physiopathology of Bone Modifications in β-Thalassemia.The ability of lumbar spine DXA and phalanx QUS to detect previous fractures in young thalassemic patients with hypogonadism, hypothyroidism, diabetes, and hepatitis-B: A 2-year subgroup analysis from the Taranto Area of Apulia Region.The effect of whole body vibration therapy on bone density in patients with thalassemia: a pilot study.Assessment Hepatomegaly and liver Enzymes in 100 Patients with beta Thalassemia Major in Mashhad, Iran.Complications of thalassemia major and their treatment.Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.Growth hormone - insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major.Prevalence of Hypoparathyroidism (HPT) in Beta Thalassemia Major.Failure of puberty in Egyptian beta thalassemic patients: experience in north east region - Dakahlia province.Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.Rheumatological complications of beta-thalassaemia: an overview.Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells.Refractive errors and ocular biometry components in thalassemia major patients.Zinc and copper status in children with Beta-thalassemia major.Long-term effects of pamidronate in thalassemic patients with severe bone mineral density deficits.Quantitative computed tomography is unreliable for measurement of bone mineral density in inadequately chelated adolescent patients with β-thalassemia major: a case-control study.Bone status in a mouse model of genetic hemochromatosis.Impact of disordered puberty on bone density in beta-thalassaemia major.Effect of VDR polymorphisms on growth and bone mineral density in homozygous beta thalassaemia.Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis.Bone disease in adult patients with β-thalassaemia major: a case-control study.Prevalence of low bone mass and vitamin D deficiency in β-thalassemia major.Osteoporosis-osteopenia syndrome in children with transfusion dependent thalassemia.Effects of stem cell transplantation on bone mineral density and vitamin D status in children with thalassemia major.Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients.Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background.Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures
P2860
Q24186036-F167355A-0BE6-4227-9179-000F79EAA259Q24200472-0A0A6143-D52F-432F-81EC-6AA366CD30ACQ24799482-E349F510-4593-46B3-92B4-64C007D95913Q31892811-83D86318-4157-48AF-84BC-10870C5D26D2Q33850994-E01CC1AC-D2D0-4925-B641-673A12AC33ECQ34069299-40BAEB77-77D1-44C9-9017-3DB2ADA94B9EQ34211460-0F3369C7-8B84-4375-984C-72F1A895EC91Q34444329-F238E092-657E-492D-84B0-3A7D407B7979Q34984712-03E85F23-A41A-4A23-9B8A-B6EB249C7023Q35225524-236F8D2A-958A-450A-87CC-A215B8A7256BQ35626388-42CFC986-C106-45E0-BDC5-97D76C356D4DQ35740873-CA2E9310-2198-4AE1-9976-0086E12DF7CBQ35909919-DEA4CA60-64F7-4C3A-9E99-327F2A55CFF9Q36014282-A8EBCA8B-5D0C-4905-B5E2-DF422D9B5DD9Q37156694-E0B5AA99-8CBE-4EF3-935B-3B20F366354EQ37354704-F7EA158C-3E4C-4072-8A47-FDE2D8CA89E1Q37560076-BFD22F52-819C-409E-B215-CE0EA24683B9Q37888721-C11AA52A-4507-45F1-BDC5-4091A2E03CD4Q38471926-849AB73C-F2B8-4822-B3EE-7C2F11434CEBQ38546820-09E0A8CA-1F98-417C-A876-F8632BA693C3Q38587893-FC906B56-D217-45A8-8737-2DEBEBFD21EEQ38855960-599F59F3-50DA-418B-8CBB-B2D1A00B9504Q38922341-3DAA72A0-1CFF-45DD-9877-E8D803745842Q39216916-E5F8ACB9-70A3-420B-BDEF-3E053D2E256FQ39413589-5BA6D865-E6B2-456B-B118-DB2CC730291BQ41066623-29F83029-1715-4BC5-B4DA-AB269E2114D9Q42326172-4C253350-25F0-40F1-A7F0-5B8A62C3CDB0Q43265083-22D534EA-8FDE-488F-80C7-D5C702046F1FQ43469075-7167E7A0-5AF8-4D19-A8B8-4741AB35745FQ43810423-4992B51A-8B03-42A0-83E2-F650325AE783Q43876487-648C5BB1-6576-4CA4-A54F-97F82691F5E2Q43969519-C5420238-88D3-4FAB-876D-6971C7EA33AEQ44005941-C7748DF6-0B72-4409-BAC6-D2AEBF2C7F26Q44552513-3193DEAE-B8AB-4CCF-9184-0DC25E303E4CQ44666419-2C0E61B3-D72D-43C1-8389-86EE8CE2CAAAQ45750120-1CE5B552-5FAF-449F-BC22-3AD7A2654F9CQ50957099-60C4D50B-01C1-4A7B-AFC1-2610939723ECQ51152359-526F0807-57F5-402C-A6AF-0BA567EB6D17Q52541808-94DA93ED-E3FF-4CD3-ACAA-2A93154AC16BQ58433652-719CDB62-3767-4919-B5FF-CDFEEA9C4D2D
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
High prevalence of low bone mass in thalassaemia major.
@en
High prevalence of low bone mass in thalassaemia major.
@nl
type
label
High prevalence of low bone mass in thalassaemia major.
@en
High prevalence of low bone mass in thalassaemia major.
@nl
prefLabel
High prevalence of low bone mass in thalassaemia major.
@en
High prevalence of low bone mass in thalassaemia major.
@nl
P2093
P2860
P1476
High prevalence of low bone mass in thalassaemia major.
@en
P2093
Hoffbrand AV
Prescott E
Yardumian A
P2860
P304
P356
10.1046/J.1365-2141.1998.01108.X
P407
P577
1998-12-01T00:00:00Z